Jewel Electrophysiology (EP) Lab Study

Inclusion Criteria

• Subjects of both genders of at least 18 years of age.
• Subjects who are scheduled for a standard EP clinical procedure where fast VT or VF may spontaneously occur or may be induced.

Exclusion Criteria

• Subjects who may require sterile access to the right upper pectoral or lower left torso regions during the planned EP procedure.
• Subjects who have taken amiodarone in the past 3 months.
• Subjects with an existing unipolar pacemaker.
• Subjects who exhibit a left ventricular ejection fraction (LVEF) less than 20% (as assessed by techniques such as echocardiography, magnetic resonance imaging, or radionuclide angiography) within the last 6 months.
• Subjects who have been diagnosed with heart failure (Class IV) or experienced an acute heart failure exacerbation within the previous 30 days.
• Subjects who exhibit unstable angina.
• Subjects with atrial fibrillation with contraindication to anticoagulation or improper anticoagulation management.
• Subjects who are participating in an investigational study of a drug, biologic, or device not currently approved for marketing.
• Subjects who are allergic to or have had a known adverse reaction to medical adhesives.
• Subjects who have active skin breakdown, erythema, or other signs of infection in the pectoral or torso regions where the study device is applied.
• Subjects with a lower abdomen circumference of less than 68.5 cm or greater than 142 cm.
• Females who are pregnant or breastfeeding, or planning to be pregnant in the next 12 months.
• Subjects who cannot provide or have diminished capacity to provide informed consent.
• Any condition that an Investigator believes would interfere with the intent of the study or is not in the best interest of the patient.
• Any patient that according to the Declaration of Helsinki is unsuitable for enrollment.